Yarbrough Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$37.1K Hold
2024
Q3
$63.3K Hold
2024
Q2
$31.4K Hold
2024
Q1
$60K Hold
2023
Q4
$107K Hold
2023
Q3
$140K Hold
2023
Q2
$309K Hold
2023
Q1
$393K Buy